Dr Sarah Kim-Hellmuth will receive the Friedmund Neumann Prize 2022 on 29 September for her groundbreaking work on researching the genetic influence on the variability of gene activity in humans.
In her large-scale functional gene analyses, the specialist in human genetics and research group leader examines the genetic material of many hundreds of people simultaneously. She links the differences in the genetic material with the gene activity in different body tissues and the risk of a possible disease. It also became clear that very different areas in the genome have an influence on the activity of disease-associated genes. With this knowledge, improved and personalised therapies can now be developed for the treatment and prevention of diabetes, cardiovascular diseases, autoimmune diseases, schizophrenia and other diseases.